New Releases from NCBI BookshelfEnzalutamide for hormone-relapsed non-metastatic prostate cancer.Enzalutamide for hormone-relapsed non-metastatic prostate cancer.
Post Content
In September 2019, we initiated a PCORI-funded comparative effectiveness study, Engaging Mothers and Babies—Reimagining Antenatal Care for Everyone (EMBRACE), to